DUO RUI PHARMA has obtained the drug registration certificate for injectable cefazolin sodium
I'm PortAI, I can summarize articles.
DUO RUI PHARMA's wholly-owned subsidiary, Hubei DUO RUI Pharmaceutical Co., Ltd., has obtained the drug registration certificate for injectable cefazolin sodium issued by the National Medical Products Administration. This medication is suitable for various infections, including lower respiratory tract infections, urinary tract infections, and abdominal cavity infections
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments